ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 60 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alken Asset Management Ltd | 850,000 | $848,000 | 3.53% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 34,448,000 | $35,346,000 | 1.72% |
Sonora Investment Management, LLC | 9,376,000 | $9,408,000 | 1.12% |
CSS LLC/IL | 7,500,000 | $7,639,000 | 0.60% |
IRON Financial LLC | 490,000 | $498,000 | 0.31% |
MACKAY SHIELDS LLC | 32,910,000 | $33,383,000 | 0.31% |
RWC Asset Management LLP | 4,550,000 | $4,642,000 | 0.24% |
Opti Capital Management, LP | 1,000 | $1,024,000 | 0.21% |
PALISADE CAPITAL MANAGEMENT, LP | 4,871,000 | $4,956,000 | 0.18% |
ADVENT CAPITAL MANAGEMENT /DE/ | 5,283,000 | $5,301,000 | 0.12% |